209 related articles for article (PubMed ID: 25979487)
21. Neuropeptide S Increases locomotion activity through corticotropin-releasing factor receptor 1 in substantia nigra of mice.
Li MS; Peng YL; Jiang JH; Xue HX; Wang P; Zhang PJ; Han RW; Chang M; Wang R
Peptides; 2015 Sep; 71():196-201. PubMed ID: 26239581
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of human and murine neuropeptide s receptor variants.
Reinscheid RK; Xu YL; Okamura N; Zeng J; Chung S; Pai R; Wang Z; Civelli O
J Pharmacol Exp Ther; 2005 Dec; 315(3):1338-45. PubMed ID: 16144971
[TBL] [Abstract][Full Text] [Related]
23. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry.
Clark SD; Duangdao DM; Schulz S; Zhang L; Liu X; Xu YL; Reinscheid RK
J Comp Neurol; 2011 Jul; 519(10):1867-93. PubMed ID: 21452235
[TBL] [Abstract][Full Text] [Related]
24. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain.
Xu YL; Gall CM; Jackson VR; Civelli O; Reinscheid RK
J Comp Neurol; 2007 Jan; 500(1):84-102. PubMed ID: 17099900
[TBL] [Abstract][Full Text] [Related]
25. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice.
Han RW; Chang M; Peng YL; Qiao LY; Yin XQ; Li W; Wang R
Peptides; 2009 Jul; 30(7):1313-7. PubMed ID: 19540430
[TBL] [Abstract][Full Text] [Related]
26. The Physio-Pharmacological Role of the NPS/NPSR System in Psychiatric Disorders: A Translational Overview.
Ghazal P
Curr Protein Pept Sci; 2016; 17(4):380-97. PubMed ID: 26680586
[TBL] [Abstract][Full Text] [Related]
27. The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S.
Fedeli A; Braconi S; Economidou D; Cannella N; Kallupi M; Guerrini R; Calò G; Cifani C; Massi M; Ciccocioppo R
Eur J Neurosci; 2009 Oct; 30(8):1594-602. PubMed ID: 19821837
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic-like effect of neuropeptide S in the rat defensive burying.
Vitale G; Filaferro M; Ruggieri V; Pennella S; Frigeri C; Rizzi A; Guerrini R; Calò G
Peptides; 2008 Dec; 29(12):2286-91. PubMed ID: 18793688
[TBL] [Abstract][Full Text] [Related]
29. Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice.
Castro AA; Casagrande TS; Moretti M; Constantino L; Petronilho F; Guerra GC; Calo' G; Guerrini R; Dal-Pizzol F; Quevedo J; Gavioli EC
Peptides; 2009 Oct; 30(10):1914-20. PubMed ID: 19616051
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative.
Ruzza C; Rizzi A; Malfacini D; Pulga A; Pacifico S; Salvadori S; Trapella C; Reinscheid RK; Calo G; Guerrini R
Pharmacol Res Perspect; 2015 Feb; 3(1):e00108. PubMed ID: 25692025
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide S increases motor activity and thermogenesis in the rat through sympathetic activation.
Ensho T; Nakahara K; Suzuki Y; Murakami N
Neuropeptides; 2017 Oct; 65():21-27. PubMed ID: 28433253
[TBL] [Abstract][Full Text] [Related]
32. The ventromedial hypothalamic nucleus plays an important role in anxiolytic-like effect of neuropeptide S.
Jiang JH; Peng YL; Zhang PJ; Xue HX; He Z; Liang XY; Chang M
Neuropeptides; 2018 Feb; 67():36-44. PubMed ID: 29195839
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.
Okamura N; Habay SA; Zeng J; Chamberlin AR; Reinscheid RK
J Pharmacol Exp Ther; 2008 Jun; 325(3):893-901. PubMed ID: 18337476
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide S inhibits release of 5-HT and glycine in mouse amygdala and frontal/prefrontal cortex through activation of the neuropeptide S receptor.
Gardella E; Romei C; Cavallero A; Trapella C; Fedele E; Raiteri L
Neurochem Int; 2013 Mar; 62(4):360-6. PubMed ID: 23411412
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide S promotes maintenance of newly formed dendritic spines and performance improvement after motor learning in mice.
Li C; Wu XJ; Li W
Peptides; 2022 Oct; 156():170860. PubMed ID: 35970276
[TBL] [Abstract][Full Text] [Related]
36. Endogenous neuropeptide S tone influences sleep-wake rhythm in rats.
Oishi M; Kushikata T; Niwa H; Yakoshi C; Ogasawara C; Calo G; Guerrini R; Hirota K
Neurosci Lett; 2014 Oct; 581():94-7. PubMed ID: 25161123
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies.
Ruzza C; Ferrari F; Guerrini R; Marzola E; Preti D; Reinscheid RK; Calo G
Pharmacol Res Perspect; 2018 Dec; 6(6):e00445. PubMed ID: 30534379
[TBL] [Abstract][Full Text] [Related]
38. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I.
Bernier V; Stocco R; Bogusky MJ; Joyce JG; Parachoniak C; Grenier K; Arget M; Mathieu MC; O'Neill GP; Slipetz D; Crackower MA; Tan CM; Therien AG
J Biol Chem; 2006 Aug; 281(34):24704-12. PubMed ID: 16790440
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.
Xu YL; Reinscheid RK; Huitron-Resendiz S; Clark SD; Wang Z; Lin SH; Brucher FA; Zeng J; Ly NK; Henriksen SJ; de Lecea L; Civelli O
Neuron; 2004 Aug; 43(4):487-97. PubMed ID: 15312648
[TBL] [Abstract][Full Text] [Related]
40. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.
Cannella N; Economidou D; Kallupi M; Stopponi S; Heilig M; Massi M; Ciccocioppo R
Neuropsychopharmacology; 2009 Aug; 34(9):2125-34. PubMed ID: 19322167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
